Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 512

1.

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.

Lee JW, Fang X, Gupta N, Serikov V, Matthay MA.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16357-62. doi: 10.1073/pnas.0907996106. Epub 2009 Aug 31.

2.

Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice.

Zhu YG, Feng XM, Abbott J, Fang XH, Hao Q, Monsel A, Qu JM, Matthay MA, Lee JW.

Stem Cells. 2014 Jan;32(1):116-25. doi: 10.1002/stem.1504.

3.

Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.

Lee JW, Krasnodembskaya A, McKenna DH, Song Y, Abbott J, Matthay MA.

Am J Respir Crit Care Med. 2013 Apr 1;187(7):751-60. doi: 10.1164/rccm.201206-0990OC.

4.

Conditioned media from mesenchymal stromal cells restore sodium transport and preserve epithelial permeability in an in vitro model of acute alveolar injury.

Goolaerts A, Pellan-Randrianarison N, Larghero J, Vanneaux V, Uzunhan Y, Gille T, Dard N, Planès C, Matthay MA, Clerici C.

Am J Physiol Lung Cell Mol Physiol. 2014 Jun 1;306(11):L975-85. doi: 10.1152/ajplung.00242.2013. Epub 2014 Mar 28.

5.

IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.

Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, Kawamata M, Kato T, Okochi H, Ochiya T.

Stem Cells. 2008 Oct;26(10):2705-12. doi: 10.1634/stemcells.2008-0034. Epub 2008 Jun 5.

6.

Clinical grade allogeneic human mesenchymal stem cells restore alveolar fluid clearance in human lungs rejected for transplantation.

McAuley DF, Curley GF, Hamid UI, Laffey JG, Abbott J, McKenna DH, Fang X, Matthay MA, Lee JW.

Am J Physiol Lung Cell Mol Physiol. 2014 May 1;306(9):L809-15. doi: 10.1152/ajplung.00358.2013. Epub 2014 Feb 14.

7.

Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice.

Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M.

Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L131-41. Epub 2007 Apr 6.

9.

Bone marrow-derived mesenchymal stem cells protect rats from endotoxin-induced acute lung injury.

Liang ZX, Sun JP, Wang P, Tian Q, Yang Z, Chen LA.

Chin Med J (Engl). 2011 Sep;124(17):2715-22.

PMID:
22040430
10.

Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.

Umar S, de Visser YP, Steendijk P, Schutte CI, Laghmani el H, Wagenaar GT, Bax WH, Mantikou E, Pijnappels DA, Atsma DE, Schalij MJ, van der Wall EE, van der Laarse A.

Am J Physiol Heart Circ Physiol. 2009 Nov;297(5):H1606-16. doi: 10.1152/ajpheart.00590.2009. Epub 2009 Sep 25.

11.

Comparison of ex vivo expansion culture conditions of mesenchymal stem cells for human cell therapy.

Pérez-Ilzarbe M, Díez-Campelo M, Aranda P, Tabera S, Lopez T, del Cañizo C, Merino J, Moreno C, Andreu EJ, Prósper F, Pérez-Simón JA.

Transfusion. 2009 Sep;49(9):1901-10. doi: 10.1111/j.1537-2995.2009.02226.x. Epub 2009 May 20.

PMID:
19497059
12.

Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats.

Zhao F, Zhang YF, Liu YG, Zhou JJ, Li ZK, Wu CG, Qi HW.

Transplant Proc. 2008 Jun;40(5):1700-5. doi: 10.1016/j.transproceed.2008.01.080.

PMID:
18589176
13.

Mesenchymal stem cell-based angiopoietin-1 gene therapy for acute lung injury induced by lipopolysaccharide in mice.

Xu J, Qu J, Cao L, Sai Y, Chen C, He L, Yu L.

J Pathol. 2008 Mar;214(4):472-81. doi: 10.1002/path.2302.

PMID:
18213733
14.

The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats.

Folkesson HG, Kuzenko SR, Lipson DA, Matthay MA, Simmons MA.

Am J Physiol Lung Cell Mol Physiol. 2012 Aug 1;303(3):L259-71. doi: 10.1152/ajplung.00395.2011. Epub 2012 Jun 1.

15.

Study of Bone Marrow and Embryonic Stem Cell-Derived Human Mesenchymal Stem Cells for Treatment of Escherichia coli Endotoxin-Induced Acute Lung Injury in Mice.

Hao Q, Zhu YG, Monsel A, Gennai S, Lee T, Xu F, Lee JW.

Stem Cells Transl Med. 2015 Jul;4(7):832-40. doi: 10.5966/sctm.2015-0006. Epub 2015 May 21.

16.

Transforming growth factor-beta1 decreases expression of the epithelial sodium channel alphaENaC and alveolar epithelial vectorial sodium and fluid transport via an ERK1/2-dependent mechanism.

Frank J, Roux J, Kawakatsu H, Su G, Dagenais A, Berthiaume Y, Howard M, Canessa CM, Fang X, Sheppard D, Matthay MA, Pittet JF.

J Biol Chem. 2003 Nov 7;278(45):43939-50. Epub 2003 Aug 20.

17.

Microvesicles Derived From Human Mesenchymal Stem Cells Restore Alveolar Fluid Clearance in Human Lungs Rejected for Transplantation.

Gennai S, Monsel A, Hao Q, Park J, Matthay MA, Lee JW.

Am J Transplant. 2015 Sep;15(9):2404-12. doi: 10.1111/ajt.13271. Epub 2015 Apr 6.

18.

Protein C and thrombomodulin in human acute lung injury.

Ware LB, Fang X, Matthay MA.

Am J Physiol Lung Cell Mol Physiol. 2003 Sep;285(3):L514-21. Epub 2003 May 16.

19.

Keratinocyte growth factor expression is suppressed in early acute lung injury/acute respiratory distress syndrome by smad and c-Abl pathways.

Chandel NS, Budinger GR, Mutlu GM, Varga J, Synenki L, Donnelly HK, Zirk A, Eisenbart J, Jovanovic B, Jain M.

Crit Care Med. 2009 May;37(5):1678-84. doi: 10.1097/CCM.0b013e31819fc81a.

PMID:
19325470
20.

Allogeneic human mesenchymal stem cells restore epithelial protein permeability in cultured human alveolar type II cells by secretion of angiopoietin-1.

Fang X, Neyrinck AP, Matthay MA, Lee JW.

J Biol Chem. 2010 Aug 20;285(34):26211-22. doi: 10.1074/jbc.M110.119917. Epub 2010 Jun 16.

Supplemental Content

Support Center